CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas.
Kim JG, Sohn SK, Chae YS, Kim DH, Baek JH, Lee KB, Lee JJ, Chung IJ, Kim HJ, Yang DH, Lee WS, Joo YD, Sohn CH.
Kim JG, et al. Among authors: lee kb, lee ws, lee jj.
Cancer Chemother Pharmacol. 2006 Jul;58(1):35-9. doi: 10.1007/s00280-005-0136-y. Epub 2005 Nov 25.
Cancer Chemother Pharmacol. 2006.
PMID: 16308699
Clinical Trial.